Abstract
Theoretically, patients with chronic bronchitis are at risk for osteoporosis. Bone metabolism was assessed in 44 male chronic bronchitics treated with oral prednisolone (C+;n=19) or with bronchodilatory drugs alone (C−;n=25). In both groups, serum osteocalcin was lower (p<0.001) than in age- and sex-matched controls (mean (ng/ml) C+ 1.0, C− 1.9, controls 4.2), while testosterone was at the lower limit of the reference range. Low trabecular bone mineral density (BMD) was noted in the C− group (median Z score −1.0), but both cortical and trabecular BMD were depressed in the C+ group (−1.0 and −1.4, respectively). In conclusion, chronic bronchitics treated with corticosteroids, even at low doses, are at risk for osteoporosis. In both groups, additional factors such as hypogonadism might be responsible for low BMD and low osteocalcin levels. A decrease in bone formation is a possible mechanism of action.
Similar content being viewed by others
References
Fletcher CM, Pride NB. Definitions of emphysema, chronic bronchitis, asthma and airflow obstruction: 25 years from the Ciba symposium. Thorax 1984;39:81–5.
Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G. Corticosteroids and bone mass in asthma: comparisons with rhumatoid arthritis and polymyalgia rheumatica. Br Med J 1986;293:1463–6.
Rüegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss: a longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983;25:615–20.
Adinoff AD, Hollister JR, Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265–8.
Riancho JA, Gonzales MJ, Del-Arco C, Amado JA, Freijanes J, Anton MA. Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax 1987;42:962–6.
Krolner B, Toft B, Nielsen ST, Tondevold E. Physical exercise as prophylaxis against involutional vertebral bone loss: a controlled trial. Clin Sci 1983;64:541–6.
Seeman E, Melton LJ, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983;75:977–83.
Raisz LG, Smith J. Osteoporosis. In: Martin TJ, Raisz LG, editors. Clinical endocrinology of calcium metabolism. New York: Marcel Dekker, 1987:201–49.
Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989;30:83–103.
Peretz A, Praet JP, Rozenberg S, Bosson D, Famaey JP, Bourdoux P. Osteocalcin and bone mineral content in rheumatoid arthritis. Clin Rheumatol 1989;8:42–8.
Rozenberg S, Ham H, Bosson D, Peretz A, Robyn C. Biological profiles of patients with discordances between cortical and trabecular bone mineral contents. Med Sci Res 1987;15:1097–9.
Geusens P, Dequecker J, Verstraeten A, Nijs J. Age-, sex-, and menopause-related changes of vertebral and peripheral bone: population study using dual and single photon absorptiometry and radiogrammetry. J Nucl Med 1986;27:1540–9.
Aloia JF, Cohn SH, Vaswani A, Yeh JK, Yuen K, Ellis K. Risk factor for postmenopausal osteoporosis. Am J Med 1985;78:95–100.
Dunlap NE, Fulmer JD. Corticosteroid therapy in asthma. Clin Chest Med 1984;5:669–83.
Bremner WJ, Vitiello V, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983;56:1278–81.
Parker LW, Levin ER, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985;60:947–52.
Delmas PD, Demiaux B, Malaval L, Chapuy MC, Meunier PJ. L'ostéocalcine (ou GLA-protéine osseuse), nouveau marqueur biologique pour 1'étude de la pathologie osseuse. Presse Med 1986;15:643–6.
Kotowicz MA, Hall S, Hunder GG, Cedel SL, Mann KG, Riggs BL. Relationship of glucocorticoid dosage to serum bone GLA-protein concentrations in patients with rheumatological disorders. Arthritis Rheum 1990;33:1487–92.
Delmas PD, Malaval L, Arlot ME, Meunier PJ. Serum bone GLA-protein compared to bone histomorphometry in endocrine diseases. Bone 1985;6:339–44.
Peretz A, Praet JP, Bosson D, Rozenberg S, Bourdoux P. Serum osteocalcin in the assessment of corticosteroid induced osteoporosis: effect of long and short term corticosteroid treatment. J Rheumatol 1989;16:363–7.
Weissman MH, Orth RW, Catherwood BD, Manolagas SC, Deftos LJ. Measures of bone loss in rheumatoid arthritis. Arch Intern Med 1986;146:701–4.
Delmas PD, Christiaensen C, Mann KG, Price PA. Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res 1990;5:5–11.
Reid IR, Chapman GE, Fraser TRC, Davies AD, Surus AS, Meyer J, et al. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab 1986; 62:379–83.
Gundberg CM, Lian JB, Gallop PM. Measurements of gammacarboxyglutamate and circulating osteocalcin in normal children and adults. Clin Chim Acta 1983;128:1–8.
Beresford JN, Gallagher JA, Poser JW, Russell RGG. Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone and glucocorticoids. Metab Bone Dis Rel Res 1984;5:229–34.
Delmas PD, Demiaux B, Malaval L, Chapuy MC, Meunier PJ. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone, Calcif Tissue Int 1986;38:60–1.
Evans DB, Russell RGG, Brown BL, Dobson PRM. Agents affecting adenylate cyclase activity modulate the stimulatory action of 1,25-dihydroxyvitamin D3 on the production of osteocalcin by human bone cells. Biochem Biophys Res Commun 1989;164:1076–85.
Vernillo AT, Rifkin BR, Hauschka PV. 5,5-Diphenylhydantoin affects osteocalcin secretion from osteoblastic rat osteosarcoma 17/2.8 cells in culture [abstract]. J Bone Miner Res 1989;4Suppl 1:128.
Nishiyama S, Tomoda S, Ohata T, Higuchi A, Matsuda I. Differences in basal and postexercise osteocalcin levels in athletic and nonathletic human. Calcif Tissue Int 1988;43:150–4.
Bell NH, Godsen RN, Henry DP, Shary J, Epstein S. The effect of muscle-building exercise on vitamin D and mineral metabolism. J Bone Mineral Res 1988;3:369–73.
Henning KN, Kim B, Seif M. Diurnal rhythm and 24-hour integrated concentrations of serum osteocalcin in normals: influence of age, sex, season, and smoking habits. Calcif Tissue Int 1990;47:284–90.
Rijs B, Krabbe S, Christiansen C, Catherwood BD, Deftos LJ. Bone turnover in male puberty: a longitudinal study. Calcif Tissue Int 1985;37:213–17.
Hajiroussou VJ, Webley M. Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. Ann Rheum Dis 1984;43:24–7.
Daniell HW. Osteoporosis of the slender smoker. Arch Intern Med 1976;136:298–304.
Khaw KT, Tzuke S, Barret-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 1988;318:1705–9.
Klaiber EL, Broverman DM, Dalen JE. Serum estradiol levels in male cigarette smokers. Am J Med 1984;77:858–62.
Rambaut PC, Johnston RS. Prolonged weightlessness and calcium loss in man. Acta Astronaut 1979;6:1113–7.
Fortenbery EJ, McDermott MT, Duncan WE. Effect of theophylline on calcium metabolism and circulating vitamin D metabolites. J Bone Miner Res 1990;5:321–4.
Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987;65:53–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Praet, J.P., Peretz, A., Rozenberg, S. et al. Risk of osteoporosis in men with chronic bronchitis. Osteoporosis Int 2, 257–261 (1992). https://doi.org/10.1007/BF01624152
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01624152